evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

3,018 questions · 3,100 findings · 369 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 774 · 25%GRADE not reported 108 · 3.5%Very low 727 · 23.5%Low 840 · 27.1%Moderate 474 · 15.3%High 177 · 5.7%

Intervention not reported

Function · participants with neglected CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Foot alignment · participants with neglected CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Gait assessment · participants with neglected CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Health‐related quality of life · participants with neglected CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Foot alignmentPirani score. Scale from: 0 to 6. A lower score indicates better alignment · participants with CTEV at initial presentation
1 finding from 1 review

Intervention not reported

Adverse events · participants with neglected CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Function ‐ · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Foot alignment Pirani score. A lower score indicates better alignment. Scale from: 0 to 6. · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review

Intervention not reported

Gait assessment · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Health‐related quality of life · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Adverse events · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review

Intervention not reported

Gait assessment · participants with CTEV at initial presentation

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Health‐related quality of life · participants with CTEV at initial presentation
1 finding from 1 review

Intervention not reported

Adverse events · participants with CTEV at initial presentation

The intervention may leads to lower adverse events (low certainty).

1 finding from 1 review

Intervention not reported

Function · participants with resistant CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Gait assessment · participants with resistant CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Health‐related quality of life · participants with resistant CTEV

The review found no eligible studies for this question.

1 finding from 1 review

Levosimendan vs dobutamine

All‐cause short‐term mortality: range 15 to 31 days · people with cardiogenic shock or low cardiac output syndrome

Levosimendan showed no clear difference in all‐cause short‐term mortality: range 15 to 31 days compared with dobutamine (low certainty).

1 finding from 1 review